Moreover, it inhibits cell growth and induces apoptosis through NF-κB suppression in Epstein–Barr virus-positive lymphoma cells [730], and suppresses cell proliferation and invasion through NF-κB/Bcl-2 and EGFR pathways in human hepatocellular carcinoma HepG2 and Bel-7402 cells [717]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.